Plus Therapeutics Regains Nasdaq Compliance; Reports $3M Stockholders' Equity and $35M+ MVLS

PLUS THERAPEUTICS, INC.

Reported stockholders' equity of $3M as of June 30, 2025, satisfying Nasdaq's minimum $2.5M Equity Rule.
Sold over $2M in common stock via a $50M equity line of credit with Lincoln Park Capital Fund since June 30.
As of August 13, 2025, market value of listed securities exceeded $35M for 20 consecutive business days, meeting the alternative MVLS requirement.
Company awaits formal Nasdaq confirmation that it has evidenced compliance with either or both listing standards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.